Acrobat Genomics

Acrobat Genomics is an early-stage, VC-backed biotech startup founded in 2022. The company's mission is to invent impactful technologies that will lead to curative therapeutics for genetic diseases. Coming from a leading CRISPR lab at Stanford University, Acrobat Genomics specializes in leveraging DNA technologies and machine learning for high-throughput biology. Located within the MBC BioLabs in San Carlos, CA, a well-equipped modern lab space, the company benefits from a rich community of companies building game-changing technologies. The startup's slogan "Accelerating safe and effective medicines to cure genetic diseases" reflects its overarching goal. Acrobat Genomics recently secured a Pre Seed Round investment on 01 January 2023 from Taihill Venture. This investment signifies confidence from a notable VC firm and reflects potential for future growth and success.